Thrivent Financial for Lutherans’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $620K | Sell |
27,434
-2,127
| -7% | -$47.3K | ﹤0.01% | 2126 |
|
|
2025
Q4 | $765K | Sell |
29,561
-2,855
| -9% | -$67.9K | ﹤0.01% | 2080 |
|
|
2025
Q3 | $835K | Sell |
32,416
-1,633
| -5% | -$40.1K | ﹤0.01% | 1876 |
|
|
2025
Q2 | $814K | Buy |
34,049
+134
| +0.4% | +$3.38K | ﹤0.01% | 1913 |
|
|
2025
Q1 | $843K | Sell |
33,915
-1,774
| -5% | -$42.5K | ﹤0.01% | 1826 |
|
|
2024
Q4 | $672K | Sell |
35,689
-534
| -1% | -$9.38K | ﹤0.01% | 2126 |
|
|
2024
Q3 | $545K | Sell |
36,223
-2,417
| -6% | -$41.3K | ﹤0.01% | 2218 |
|
|
2024
Q2 | $1.1M | Sell |
38,640
-28,224
| -42% | -$803K | ﹤0.01% | 1819 |
|
|
2024
Q1 | $1.95M | Sell |
66,864
-11,047
| -14% | -$339K | ﹤0.01% | 1438 |
|
|
2023
Q4 | $2.63M | Sell |
77,911
-13,847
| -15% | -$405K | 0.01% | 1194 |
|
|
2023
Q3 | $2.81M | Buy |
91,758
+47,764
| +109% | +$1.72M | 0.01% | 1067 |
|
|
2023
Q2 | $1.76M | Sell |
43,994
-1,476
| -3% | -$61K | ﹤0.01% | 1425 |
|
|
2023
Q1 | $1.86M | Sell |
45,470
-1,593
| -3% | -$63.4K | ﹤0.01% | 1347 |
|
|
2022
Q4 | $1.82M | Sell |
47,063
-306
| -0.6% | -$14.9K | ﹤0.01% | 1319 |
|
|
2022
Q3 | $2.52M | Buy |
47,369
+2,730
| +6% | +$152K | 0.01% | 1092 |
|
|
2022
Q2 | $2.6M | Buy |
44,639
+8,377
| +23% | +$549K | 0.01% | 1086 |
|
|
2022
Q1 | $2.77M | Buy |
36,262
+12
| +0% | +$800 | 0.01% | 1141 |
|
|
2021
Q4 | $2.18M | Buy |
36,250
+317
| +0.9% | +$17.5K | ﹤0.01% | 1334 |
|
|
2021
Q3 | $2.01M | Sell |
35,933
-57
| -0.2% | -$3.29K | ﹤0.01% | 1349 |
|
|
2021
Q2 | $2.18M | Sell |
35,990
-42
| -0.1% | -$2.66K | ﹤0.01% | 1368 |
|
|
2021
Q1 | $2.52M | Buy |
36,032
+72
| +0.2% | +$5.14K | 0.01% | 1267 |
|
|
2020
Q4 | $2.15M | Buy |
35,960
+519
| +1% | +$30.4K | 0.01% | 1274 |
|
|
2020
Q3 | $2.13M | Buy |
35,441
+185
| +0.5% | +$10.7K | 0.01% | 1121 |
|
|
2020
Q2 | $1.85M | Buy |
35,256
+282
| +0.8% | +$11.8K | 0.01% | 1114 |
|
|
2020
Q1 | $1.17M | Buy |
34,974
+1,746
| +5% | +$72.5K | ﹤0.01% | 1207 |
|
|
2019
Q4 | $1.5M | Buy |
33,228
+226
| +0.7% | +$9.6K | ﹤0.01% | 1197 |
|
|
2019
Q3 | $1.26M | Buy |
+33,002
| New | +$1.32M | ﹤0.01% | 1262 |
|
|
2017
Q2 | – | Sell |
-38,653
| Closed | -$1.76M | – | 2062 |
|
|
2017
Q1 | $1.76M | Buy |
+38,653
| New | +$1.67M | 0.01% | 903 |
|
Other funds holding PCRX
DPCM
VPM
VCM
